Ardance-L 10 mg+5 mg (Tablet)
Unit Price: ৳ 35.00 (3 x 10: ৳ 1,050.00)
Strip Price: ৳ 350.00
Medicine Details
Category | Details |
---|---|
Generic | Empagliflozin linagliptin |
Company | Pharmacil limited |
Also available as |
Indications
- Adjunct to diet and exercise
- Improves glycemic control
- Type 2 diabetes mellitus
Pharmacology
- Inhibits DPP-4 enzyme
- Increases concentrations of active incretin hormones
- Stimulates insulin release
- Decreases glucagon levels
- Regulates glucose homeostasis
- Inhibits Sodium-glucose co-transporter 2 (SGLT2)
Dosage & Administration
- Recommended dose: 10 mg Empagliflozin and 5 mg Linagliptin once daily
- Increases to 25 mg Empagliflozin and 5 mg Linagliptin once daily
- Assess renal function before initiating
- Do not initiate if eGFR is below 45 mL/min/1.73 m^2
Interaction
- Coadministration with diuretics increases urine volume
- Risk for hypoglycemia with insulin or insulin secretagogues
- Inducers of P-glycoprotein or CYP3A4 enzymes may reduce efficacy
- Increases urinary glucose excretion
- Interference with 1,5-anhydroglucitol (1,5-AG) assay
Contraindications
- Severe renal impairment or end-stage renal disease
- Hypersensitivity reactions to Linagliptin or Empagliflozin
Side Effects
- Pancreatitis
- Ketoacidosis
- Volume depletion
- Urosepsis and Pyelonephritis
- Hypoglycemia
- Necrotizing Fasciitis of the Perineum
- Genital Mycotic Infections
- Hypersensitivity Reactions
- Severe and Disabling Arthralgia
- Bullous Pemphigoid
- Heart Failure
Pregnancy & Lactation
- Not recommended in second and third trimesters
- Limited data available in pregnant women
- Risks associated with poorly controlled diabetes in pregnancy
Precautions & Warnings
- Pancreatitis
- Hypotension
- Acute kidney injury
- Impairment in renal function
- Urosepsis and Pyelonephritis
- Hypoglycemia
- Genital Mycotic Infections
- Hypersensitivity
- Necrotizing Fasciitis of the Perineum
- Heart Failure
Overdose Effects
- Contact Poison Control Center
- Usual supportive measures
- Removal of unabsorbed material from the gastrointestinal tract
Therapeutic Class
- Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors
Storage Conditions
- Store below 30°C temperature
- Keep away from light and wet place
- Keep out of reach of children